Real-Time Cholangioscopy Artificial Intelligence Evaluation of Biliary Strictures
Launched by MAYO CLINIC · Mar 9, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new technology that uses artificial intelligence to help doctors better understand the causes of biliary strictures—narrowing in the bile ducts that can cause various health issues. The goal is to see if this technology, called a convolutional neural network (CNN), can accurately identify the reasons for these strictures while doctors are performing a specific procedure known as peroral cholangioscopy (POC).
To participate in this study, you need to be at least 18 years old and be scheduled for a POC during a related procedure called endoscopic retrograde cholangiopancreatography (ERCP). Pregnant women and non-English speakers can also join the study, as the technology does not pose any additional risks. If you choose to participate, you will have the opportunity to receive care that may help your doctors make better decisions about your treatment. Overall, this trial could lead to improved ways to diagnose and treat problems with bile ducts.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years old
- • Anticipation that patient may undergo POC during an endoscopic retrograde cholangioscopy
- • Pregnant patients can be included in the study. Use of the POC-CNN does not convey any new risk to the patient nor fetus.
- • Non-English speaking subjects will be included in the study. Consent for the procedure itself is always done with the assistance of an interpreter via telephone or video. Use of the POC-CNN will be discussed with all patients via this interpreter during the procedure consent.
- Exclusion Criteria:
- • Age \<18 years old
- • No indication that cholangioscopy will be performed during endoscopic retrograde cholangiopancreatography (ERCP)
- • Prisoner
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Worcester, Massachusetts, United States
Rochester, Minnesota, United States
Patients applied
Trial Officials
Vinay Chandrasekhara, MD
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials